Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation.

Abstract

The authors summarize recent updates in the prevention and management of cytomegalovirus (CMV) in solid organ transplant (SOT) recipients with a focus on CMV seronegative recipients of organs from seropositive donors (CMV D+/R-) who are at highest risk of CMV infection and disease. They discuss advantages of preemptive therapy for CMV disease prevention in CMV D+/R- liver transplant recipients, letermovir for CMV prophylaxis, and updates in the development of monoclonal antibodies and vaccines as immune-based preventative strategies. They review the roles of maribavir and virus-specific T cells for management of resistant or refractory CMV infection in SOT recipients.

• Authors: Kathleen M Doss, Madeleine R Heldman, Ajit P Limaye
• Journal: Infectious disease clinics of North America (Infect Dis Clin North Am) (Nov 20 2023) ISSN: 1557-9824 [Electronic] United States
• PMID: 37989636 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2023 Elsevier Inc. All rights reserved.